Proto Labs (NYSE:PRLB) Stock Rating Lowered by Wall Street Zen

Proto Labs (NYSE:PRLBGet Free Report) was downgraded by stock analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Saturday.

A number of other research firms also recently commented on PRLB. Zacks Research downgraded shares of Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 3rd. Benchmark increased their price target on Proto Labs from $70.00 to $91.00 and gave the company a “buy” rating in a research report on Thursday, July 2nd. Finally, Weiss Ratings downgraded Proto Labs from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, June 29th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Proto Labs has a consensus rating of “Moderate Buy” and a consensus price target of $65.33.

Read Our Latest Analysis on Proto Labs

Proto Labs Stock Up 0.5%

Shares of PRLB opened at $77.78 on Friday. Proto Labs has a twelve month low of $38.48 and a twelve month high of $83.15. The stock has a market capitalization of $1.85 billion, a P/E ratio of 73.38 and a beta of 1.38. The company has a 50 day moving average of $75.88 and a 200-day moving average of $65.01.

Proto Labs (NYSE:PRLBGet Free Report) last announced its quarterly earnings data on Friday, May 1st. The industrial products company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Proto Labs had a net margin of 4.71% and a return on equity of 4.15%. The business had revenue of $139.34 million for the quarter, compared to analyst estimates of $135.31 million. During the same quarter in the previous year, the firm posted $0.33 earnings per share. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. On average, sell-side analysts anticipate that Proto Labs will post 1.37 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Proto Labs news, Director Sven Wehrwein sold 2,000 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $77.28, for a total transaction of $154,560.00. Following the completion of the sale, the director owned 32,505 shares of the company’s stock, valued at $2,511,986.40. This trade represents a 5.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Michael R. Kenison sold 16,030 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $69.49, for a total transaction of $1,113,924.70. Following the sale, the insider owned 18,683 shares of the company’s stock, valued at approximately $1,298,281.67. This represents a 46.18% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 25,663 shares of company stock valued at $1,804,727. Insiders own 1.30% of the company’s stock.

Institutional Trading of Proto Labs

Several institutional investors have recently added to or reduced their stakes in PRLB. Pacer Advisors Inc. boosted its position in shares of Proto Labs by 74.2% in the first quarter. Pacer Advisors Inc. now owns 5,653 shares of the industrial products company’s stock valued at $322,000 after acquiring an additional 2,407 shares during the period. Bank of America Corp DE increased its position in Proto Labs by 38.3% during the first quarter. Bank of America Corp DE now owns 129,113 shares of the industrial products company’s stock worth $7,362,000 after acquiring an additional 35,784 shares during the period. Edgestream Partners L.P. acquired a new stake in Proto Labs in the 1st quarter worth about $1,084,000. Amundi boosted its holdings in Proto Labs by 16.9% in the 1st quarter. Amundi now owns 14,082 shares of the industrial products company’s stock valued at $803,000 after purchasing an additional 2,031 shares during the period. Finally, Quantinno Capital Management LP boosted its holdings in Proto Labs by 98.9% in the 1st quarter. Quantinno Capital Management LP now owns 27,716 shares of the industrial products company’s stock valued at $1,580,000 after purchasing an additional 13,781 shares during the period. 84.54% of the stock is currently owned by institutional investors.

About Proto Labs

(Get Free Report)

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.

Featured Articles

Analyst Recommendations for Proto Labs (NYSE:PRLB)

Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.